Increased neutrophil-to-lymphocyte ratio is associated with disease-specific mortality in patients with penile cancer

[1]  Jianqing Xu,et al.  Systemic inflammation score predicts postoperative prognosis of patients with clear-cell renal cell carcinoma , 2015, British Journal of Cancer.

[2]  P. Spiess,et al.  Re: Oliver W. Hakenberg, Eva M. Compérat, Suks Minhas, Andrea Necchi, Chris Protzel, Nick Watkin. EAU Guidelines on Penile Cancer: 2014 Update. Eur Urol 2015;67:142-50. , 2015, European urology.

[3]  P. Kornprat,et al.  The lymphocyte to monocyte ratio in peripheral blood represents a novel prognostic marker in patients with pancreatic cancer , 2015, Clinical chemistry and laboratory medicine.

[4]  G. Pond,et al.  Concurrent chemoradiotherapy for men with locally advanced penile squamous cell carcinoma. , 2014, Clinical genitourinary cancer.

[5]  K. Pummer,et al.  Low preoperative lymphocyte-monocyte ratio (LMR) represents a potentially poor prognostic factor in nonmetastatic clear cell renal cell carcinoma. , 2014, Urologic oncology.

[6]  A. Zlotta,et al.  Pre-treatment neutrophil-to-lymphocyte ratio as predictor of adverse outcomes in patients undergoing radical cystectomy for urothelial carcinoma of the bladder , 2014, British Journal of Cancer.

[7]  K. Pummer,et al.  Validation of the pretreatment derived neutrophil–lymphocyte ratio as a prognostic factor in a European cohort of patients with upper tract urothelial carcinoma , 2014, British Journal of Cancer.

[8]  U. Langsenlehner,et al.  The elevated preoperative platelet-to-lymphocyte ratio predicts poor prognosis in breast cancer patients , 2014, British Journal of Cancer.

[9]  Wenhui Qian,et al.  Prognostic Role of NLR in Urinary Cancers: A Meta-Analysis , 2014, PloS one.

[10]  Shigemi Matsumoto,et al.  Neutrophil-to-lymphocyte ratio for predicting palliative chemotherapy outcomes in advanced pancreatic cancer patients , 2014, Cancer medicine.

[11]  Yufeng Cheng,et al.  The clinical significance of tumor-infiltrating neutrophils and neutrophil-to-CD8+ lymphocyte ratio in patients with resectable esophageal squamous cell carcinoma , 2014, Journal of Translational Medicine.

[12]  M. Kuczyk,et al.  Elevated C-reactive protein values predict nodal metastasis in patients with penile cancer , 2013, BMC Urology.

[13]  N. Muñoz,et al.  Epidemiologic profile, sexual history, pathologic features, and human papillomavirus status of 103 patients with penile carcinoma , 2013, World Journal of Urology.

[14]  P. Kornprat,et al.  Increased neutrophil-lymphocyte ratio is a poor prognostic factor in patients with primary operable and inoperable pancreatic cancer , 2013, British Journal of Cancer.

[15]  V. Gebski,et al.  Markers of systemic inflammation predict survival in patients with advanced renal cell cancer , 2013, British Journal of Cancer.

[16]  M. Cronauer,et al.  High CRP values predict poor survival in patients with penile cancer , 2013, BMC Cancer.

[17]  A. Tatlışen,et al.  Can Neutrophil-Lymphocyte Ratio and Lymph Node Density Be Used as Prognostic Factors in Patients Undergoing Radical Cystectomy? , 2013, TheScientificWorldJournal.

[18]  S. Robson,et al.  Predictors of Endoscopic Inflammation in Patients With Ulcerative Colitis in Clinical Remission , 2013, Inflammatory bowel diseases.

[19]  R. Silva,et al.  Carcinoma epidermoide do pênis: estudo clínico-patológico de 34 casos , 2011 .

[20]  Y. K. Park,et al.  Elevated preoperative neutrophil to lymphocyte ratio predicts poor survival following resection in late stage gastric cancer , 2011, Journal of surgical oncology.

[21]  V. Baracos,et al.  Neutrophil/lymphocyte ratio predicts chemotherapy outcomes in patients with advanced colorectal cancer , 2011, British Journal of Cancer.

[22]  D. Talwar,et al.  An inflammation-based prognostic score (mGPS) predicts cancer survival independent of tumour site: a Glasgow Inflammation Outcome Study , 2011, British Journal of Cancer.

[23]  J. Nakashima,et al.  Pretreatment neutrophil-to-lymphocyte ratio as an independent predictor of recurrence in patients with nonmetastatic renal cell carcinoma. , 2010, The Journal of urology.

[24]  J. Neoptolemos,et al.  Preoperative platelet-lymphocyte ratio is an independent significant prognostic marker in resected pancreatic ductal adenocarcinoma. , 2009, American journal of surgery.

[25]  X. Yao,et al.  The value of squamous cell carcinoma antigen in the prognostic evaluation, treatment monitoring and followup of patients with penile cancer. , 2008, The Journal of urology.

[26]  D. Gomez,et al.  Impact of systemic inflammation on outcome following resection for intrahepatic cholangiocarcinoma , 2008, Journal of surgical oncology.

[27]  X. Yao,et al.  The prognostic significance of p53, Ki‐67, epithelial cadherin and matrix metalloproteinase‐9 in penile squamous cell carcinoma treated with surgery , 2007, BJU international.

[28]  M. ChB.,et al.  Neutrophil‐lymphocyte ratio as a prognostic factor in colorectal cancer , 2005, Journal of surgical oncology.

[29]  C. J. Hansson.  Cancer of the Penis and Its Treatment , 1938 .

[30]  E. Compérat,et al.  EAU guidelines on penile cancer: 2014 update. , 2015, European urology.

[31]  W. Hellstrom,et al.  J Urol , 2014 .

[32]  R. Silva,et al.  Squamous cell carcinoma of the penis: clinicopathologic study of 34 cases. , 2011, Anais brasileiros de dermatologia.

[33]  V. Bhatt,et al.  Usefulness of the Neutrophil-to-Lymphocyte Ratio in Predicting Short- and Long-Term Mortality in Breast Cancer Patients , 2011, Annals of Surgical Oncology.

[34]  Magdalena Kowalewska,et al.  Systemic inflammation as a confounding factor in cancer biomarker discovery and validation , 2010, Nature Reviews Cancer.

[35]  R. Záhorec.  Ratio of neutrophil to lymphocyte counts--rapid and simple parameter of systemic inflammation and stress in critically ill. , 2001, Bratislavske lekarske listy.

[36]  S. Kamidono.  [Cancer of the penis and its treatment]. , 1992, Nihon Hinyokika Gakkai zasshi. The japanese journal of urology.

[37]  B. Dai,et al.  Patients and Methods Patient Selection and Data Collection , 2022 .